jabrik edan: SHIVOM - THE FUTURE IS YOUR GENOME! OWN IT

This time we found an interesting project, which is the goal of the genome with the help of detachment. Thus, the Shivom project will allow for the operation of the platform-generated tokens. In this article, we will discuss how the project will help you to find out what the same thing is. . DNA.

THE SHIVOM ECOSYSTEM

Shivom is creating a genomics ecosystem on the blockchain. We will offer an open marketplace for healthcare providers to add their apps and services, alongside genomic data analytics and personalized medicine.

Transform genomic data into useable information Break down silos data Help accelerate clinical trials Facilitate drug research and development Sponsorship sequencing projects to get access to relevant data.

WHY SHOULD YOU CHOOSE SHIVOM?

To make the direct-to-consumer business more open, fair, and beneficial to all users, the Shivom platform uses blockchain technology to create a disruptive genomics ecosystem. It ensures data is owned by the data donors themselves. It ensures a transparent and secure bridge to organizations interested in using that data.

• Genome data donors own their data and access rights

• Donors gain rewards for sharing their genomic data on the blockchain by selling access rights directly to third party institutions such as pharmaceutical companies

• Pharmaceutical companies use the Shivom platform to refine drug development

• Shivom users have full and fine-grained control of who can access the data even after a third party institution has access to it

• Patients get personalized health, well-being, and lifestyle information

• A dynamic ecosystem is created and continuously refined in which the community can identify and remove potential health roadblocks before they become serious

WHY NOW?

The cost of DNA sequencing has fallen significantly. It is anticipated that by the end of the decade it will be possible to generate a person's entire genome for less than $ 100. Looking forward, we will see dramatically lower costs for genomics analysis services. This will make personalized healthcare insights accessible to almost all individuals around the globe. As recently as January 2017, the worldwide leading sequencing provider Illumina unveiled a new sequencer, the NovaSeq, that the company reports will provide a whole genome for less than $ 100. This presents a new dawn for access to personalized and precision healthcare on a global scale.

how does shivom work

Pharmaceutical, biotech, insurance and data donors all within the same hub

Genomics and artificial intelligence present a unique opportunity to revolutionize R & D programs, especially screening for drug targets and corresponding drug candidates. The significant cost associated with drug development is linked to the ability to access high-quality and validated datasets from patients.

We are currently engaging with partners in leading pharmaceutical / biotech companies and clinical research organizations (CROs) to allow access to our services, as well as offer the opportunity to sponsor genomic testing on a mass level.

The data will not be owned by any company, and the Shivom platform will facilitate pharmaceutical companies' use of data by providing attractive rewards and a market access model that directly engages with data owners.

The model will allow access to study and control of patients through an app marketplace for phenotypic screening and more.

TOKENS

The OmiX Token:

The OmiX token is a key component that enables buying, trading, incentivizing and other services. The token is the fuel of the Shivom ecosystem, as well as part of the governance of the system.

Benefits of OmiX tokens:

• Ability to acquire premium services in the Shivom ecosystem

• Ability to acquire genome sequencing kits

• Ability to sponsor sequencing projects

• Ability to acquire access to health / fitness apps from 3rd party providers

• Ability to access the genome database

• Ability to pay donors for data / participation in research studies

• Ability for service providers to use the platform

Token Sale

990M OmiX tokens will be sold during the ICO process.

Community

90M OmiX Tokens will be distributed to the community to grow and nurture the Shivom ecosystem, for bounty programs to leverage network effects, and for community initiatives to reward developers, entrepreneurs, and strategists.

Founders

420M OmiX will be allocated for founders to support the development of the Shivom ecosystem and their continued long-term alignment with the project.

Advisors

300M OmiX will be allocated for the early backers and a global network of advisors.

Incentivizing Growth Pool

600M OmiX will be secured in a smart contract, allocated to the database, and introduced into circulation as a rewards for data generation.

Company Reserve

600M OmiX will be maintained by the Foundation as a reserve fund for future data contribution, running the Foundation and associated non-profit R & D efforts. The

Foundation maintains all authority to utilize a few or the majority of the reserve tokens for future external investors

TOKEN SALE: USE OF PROCEEDS

The level of funding received dictates the distribution of funds. However, reserve structure allows us to reduce the volatility along the way while achieving long-term objectives.

20% Platform Development

Database building, UI, APIs, and metadata curating. A large part of this budget will be used to make the platform secure and scalable. From there we will implement new features and create the open marketplace.

11% Operations & Business Development

Day-to-day operations, team building (developers, geneticists, marketers and product managers). Forming the Foundation.

10% Non-Profit R & D Platform

Drug discovery platform combining elements of Big Data analytics, artificial intelligence, genomics, proteomics, lipidomics, and metabolomics.

21% Marketing & Forming Partnerships

Ongoing community-building events public communications via traditional marketing channels and persona-based approaches. This also includes educational materials, roadshows, collaboration with other genomics-initiatives, organizing events and conferences, and KOL management.

5% Legal

Regulatory compliance for all markets Shivom operates in.

2% Initial PoC

First sequencing project in hospitals in rural India.

6% Data Storage

Forecasted to sustain the platform during the first few years.

25% Laboratories

Setting up a global network of laboratories and counseling services.